• Promoting Taiwan’s Biotechnology Development

  • Center for Clinical Trial Training in Taiwan

    FMPAT has endeavored to upgrade the biotechnology environment for long time. FMPAT is invited by Board of Science and Technology of Executive Yuan to participate in Bio Taiwan Committee (BTC), which is a high-level committee aims to form biotechnology policy for Taiwan. Recently, FMPAT participated in several cell and gene therapies projects, including regulation regarding cells and gene therapy medicinal products as well as regulation on Taiwan’s biotechnology development.

    To promote the quality of Taiwan’s clinical trial research and facilitate the development of pharmacy industries, FMPAT has endeavored to organize clinical trial training programs for over 20 years. FMPAT also held international conference and national forum for medical regulation harmonization with ICH. Meanwhile, through education initiations and public communication activities, FMPAT ensures patients right in clinical trial and promotes sound management in clinical trial risk.

     

     

Center for Clinical Trial Training in Taiwan

FMPAT has endeavored to upgrade the biotechnology environment for long time. FMPAT is invited by Board of Science and Technology of Executive Yuan to participate in Bio Taiwan Committee (BTC), which is a high-level committee aims to form biotechnology policy for Taiwan. Recently, FMPAT participated in several cell and gene therapies projects, including regulation regarding cells and gene therapy medicinal products as well as regulation on Taiwan’s biotechnology development.

To promote the quality of Taiwan’s clinical trial research and facilitate the development of pharmacy industries, FMPAT has endeavored to organize clinical trial training programs for over 20 years. FMPAT also held international conference and national forum for medical regulation harmonization with ICH. Meanwhile, through education initiations and public communication activities, FMPAT ensures patients right in clinical trial and promotes sound management in clinical trial risk.

 

 

  • Promoting Taiwan’s Biotechnology Development

  • Center for Clinical Trial Training in Taiwan

    FMPAT has endeavored to upgrade the biotechnology environment for long time. FMPAT is invited by Board of Science and Technology of Executive Yuan to participate in Bio Taiwan Committee (BTC), which is a high-level committee aims to form biotechnology policy for Taiwan. Recently, FMPAT participated in several cell and gene therapies projects, including regulation regarding cells and gene therapy medicinal products as well as regulation on Taiwan’s biotechnology development.

    To promote the quality of Taiwan’s clinical trial research and facilitate the development of pharmacy industries, FMPAT has endeavored to organize clinical trial training programs for over 20 years. FMPAT also held international conference and national forum for medical regulation harmonization with ICH. Meanwhile, through education initiations and public communication activities, FMPAT ensures patients right in clinical trial and promotes sound management in clinical trial risk.

     

     

Center for Clinical Trial Training in Taiwan

FMPAT has endeavored to upgrade the biotechnology environment for long time. FMPAT is invited by Board of Science and Technology of Executive Yuan to participate in Bio Taiwan Committee (BTC), which is a high-level committee aims to form biotechnology policy for Taiwan. Recently, FMPAT participated in several cell and gene therapies projects, including regulation regarding cells and gene therapy medicinal products as well as regulation on Taiwan’s biotechnology development.

To promote the quality of Taiwan’s clinical trial research and facilitate the development of pharmacy industries, FMPAT has endeavored to organize clinical trial training programs for over 20 years. FMPAT also held international conference and national forum for medical regulation harmonization with ICH. Meanwhile, through education initiations and public communication activities, FMPAT ensures patients right in clinical trial and promotes sound management in clinical trial risk.